Antisense approaches in drug discovery and development

Prog Drug Res. 2005:63:227-74. doi: 10.1007/3-7643-7414-4_10.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / genetics
  • Drug Design*
  • Genes, ras
  • Humans
  • Inhibitor of Apoptosis Proteins
  • Microtubule-Associated Proteins / antagonists & inhibitors
  • Microtubule-Associated Proteins / genetics
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / genetics
  • Oligonucleotides, Antisense / therapeutic use*
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / genetics
  • Survivin
  • Thionucleotides / therapeutic use
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vascular Endothelial Growth Factor A / genetics

Substances

  • Antineoplastic Agents
  • BIRC5 protein, human
  • Inhibitor of Apoptosis Proteins
  • Microtubule-Associated Proteins
  • Neoplasm Proteins
  • Oligonucleotides, Antisense
  • Survivin
  • Thionucleotides
  • Vascular Endothelial Growth Factor A
  • oblimersen
  • Cyclic AMP-Dependent Protein Kinases
  • Protein Kinase C